KORU Medical Systems Annual report pursuant to Section 13 and 15(d)

Annual report pursuant to Section 13 and 15(d)

CONTINGENT LIABILITY

CONTINGENT LIABILITY	12 Months Ended
Feb. 28, 2017
Commitments and Contingencies Disclosure [Abstract]
CONTINGENT LIABILITY	NOTE 7 CONTINGENT LIABILITY On March 25, 2016, the Company’s legal counsel, who had represented the Company in its patent litigation withdrew as legal counsel, after discussions regarding whether they were the most suited to be our representative in this action and verbally waived payment on any remaining open invoices which totaled $0.5 million. The Company does not believe it is responsible for these fees nor does it believe that the law firm will take action to collect these fees. The unpaid legal fees have been reversed.

CONTINGENT LIABILITY

12 Months Ended

Feb. 28, 2017

Commitments and Contingencies Disclosure [Abstract]

NOTE 7 CONTINGENT LIABILITY

On March 25, 2016, the Company’s legal counsel, who had represented the Company in its patent litigation withdrew as legal counsel, after discussions regarding whether they were the most suited to be our representative in this action and verbally waived payment on any remaining open invoices which totaled $0.5 million. The Company does not believe it is responsible for these fees nor does it believe that the law firm will take action to collect these fees. The unpaid legal fees have been reversed.